Envestnet Portfolio Solutions Inc. Buys 12,945 Shares of CME Group Inc. $CME

Envestnet Portfolio Solutions Inc. lifted its position in shares of CME Group Inc. (NASDAQ:CME) by 21.7% during the fourth quarter, Holdings Channel reports. The firm owned 72,534 shares of the financial services provider’s stock after acquiring an additional 12,945 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in CME Group were worth $19,808,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of CME. Asset Dedication LLC grew its position in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares during the period. FNY Investment Advisers LLC bought a new position in CME Group in the 4th quarter worth about $27,000. Global Wealth Strategies & Associates boosted its stake in CME Group by 1,250.0% in the 4th quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 100 shares during the period. Legacy Wealth Managment LLC ID increased its holdings in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 71 shares during the period. Finally, Anfield Capital Management LLC boosted its stake in CME Group by 197.4% during the fourth quarter. Anfield Capital Management LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after buying an additional 75 shares during the period. 87.75% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CME. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Erste Group Bank raised CME Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, March 5th. UBS Group reissued a “neutral” rating and issued a $310.00 price target on shares of CME Group in a report on Friday, February 6th. Barclays lowered their price target on CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a research report on Thursday, April 23rd. Finally, Jefferies Financial Group decreased their price target on shares of CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research note on Thursday, April 9th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, CME Group currently has an average rating of “Moderate Buy” and a consensus target price of $305.29.

CME Group Price Performance

CME opened at $302.37 on Wednesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $257.17 and a 52-week high of $329.16. The stock has a market capitalization of $109.57 billion, a P/E ratio of 25.80, a P/E/G ratio of 3.69 and a beta of 0.23. The company’s 50-day simple moving average is $297.54 and its two-hundred day simple moving average is $288.74.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the previous year, the firm posted $2.80 EPS. The firm’s revenue was up 14.5% on a year-over-year basis. As a group, analysts predict that CME Group Inc. will post 12.26 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.7%. The ex-dividend date is Tuesday, June 9th. CME Group’s payout ratio is 44.37%.

Insider Buying and Selling

In related news, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the firm’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the sale, the general counsel owned 7,192 shares in the company, valued at $2,397,597.04. The trade was a 31.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 48,544 shares of company stock worth $14,689,807 in the last quarter. Company insiders own 0.30% of the company’s stock.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME continues to benefit from solid fundamentals, including a recent earnings beat with stronger-than-expected revenue and EPS, plus a healthy dividend that supports shareholder returns.
• Positive Sentiment: New activity in CME-linked derivatives products, including growing interest in interest-rate and crypto-related futures, suggests the exchange remains well positioned to capture trading volume and product demand.
• Neutral Sentiment: Market commentary also noted CME as an alternative for investors concerned about correlation risk, which reflects the company’s role as a defensive financial market infrastructure name.
• Neutral Sentiment: The company adjourned voting on Class B proposals after a quorum shortfall at its 2026 annual meeting, a procedural issue that is unlikely to change the business outlook but may keep some attention on governance matters. Article Title
• Negative Sentiment: CEO Terrence Duffy sold 35,000 shares and insider Hilda Harris Piell sold 5,753 shares, which can weigh on sentiment because investors often view insider selling as a cautious signal. Article Title

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.